Treatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
Andrew Patrick Ambrosy, MD, MPH
Rethinking Risk in Heart Failure with Preserved Ejection Fraction
Alexandria May, PharmD, BCPS
Javed Butler, MD, MPH, MBA
Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Benjamin Levine, MD, FACC
Examining Barriers to Digital Healthcare in PAH
Daniel Lachant, D.O.
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Advances in Sports Cardiology: Updates from ACC 2026
Jeffrey Hsu, MD, PhD
Counseling Patients on Disease Progression in ATTR-CM
Joban Vaishnav, MD
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Florian Rader, MD
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
Rethinking Thromboembolic Risk in ATTR-CM Care
Targeting Macrophages in Pulmonary Arterial Hypertension
Fatty Acid Profiles May Be Linked to PAH Risk
Ryan Quigley
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
Hallie Blevins, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.